Cart
sales@molnova.com
WY-14643 (Pirinixic Acid)
CAS No. 50892-23-4
WY-14643 (Pirinixic Acid)( Pirinixic Acid )
Catalog No. M14744 CAS No. 50892-23-4
WY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPARα with EC50 of 1.5 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 10MG | 39 | In Stock |
|
| 25MG | 55 | In Stock |
|
| 50MG | 67 | In Stock |
|
| 100MG | 100 | In Stock |
|
| 200MG | 140 | In Stock |
|
| 500MG | 232 | In Stock |
|
| 1G | 343 | In Stock |
|
Biological Information
-
Product NameWY-14643 (Pirinixic Acid)
-
NoteResearch use only, not for human use.
-
Brief DescriptionWY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPARα with EC50 of 1.5 μM.
-
DescriptionWY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPARα with EC50 of 1.5 μM.
-
In Vitro——
-
In Vivo——
-
SynonymsPirinixic Acid
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPARα
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number50892-23-4
-
Formula Weight323.8
-
Molecular FormulaC14H14ClN3O2S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 52 mg/mL (160.59 mM); DMSO: 65 mg/mL (200.74 mM)
-
SMILESO=C(O)CSC1=NC(NC2=CC=CC(C)=C2C)=CC(Cl)=N1
-
Chemical Name[[4-chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]-acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Issemann I, et al. Nature. 1990, 347(6294), 645-650.
2. Staels B, et al. Nature. 1998, 393(6687), 790-793.
molnova catalog
related products
-
CC618
CC618 is a selective PPARβ/δ antagonist with an IC50 of 10.0 μM.
-
Chiglitazar
Chiglitazar (CS-038, CS038) is a potent, dual PPARα/γ dual agonist with EC50 of 1.2, 0.08, 1.7 uM for PPARα, PPARγ and PPARδ, respectively.
-
Seladelpar
A potent, selective, orally bioavailable PPARδ agonist for the treatment of dyslipidemia, metabolic syndrome, type 2 diabetes, and non-alcoholic steatohepatitis (NASH).
